Cocrystal Pharma, Inc.

NASDAQ:COCP

2.04 (USD) • At close October 17, 2024
Bedrijfsnaam Cocrystal Pharma, Inc.
Symbool COCP
Munteenheid USD
Prijs 2.04
Beurswaarde 20,754,552
Dividendpercentage 0%
52-weken bereik 1.33 - 3.1
Industrie Biotechnology
Sector Healthcare
CEO Dr. Sam Lee Ph.D.
Website https://www.cocrystalpharma.com

An error occurred while fetching data.

Over Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside

Vergelijkbare Aandelen

Applied Therapeutics, Inc. logo

Applied Therapeutics, Inc.

APLT

8.63 USD

Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc.

MBRX

2.36 USD

Evogene Ltd. logo

Evogene Ltd.

EVGN

2.14 USD

Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc.

SPRO

1.285 USD

IN8bio, Inc. logo

IN8bio, Inc.

INAB

0.23 USD

Neoleukin Therapeutics, Inc. logo

Neoleukin Therapeutics, Inc.

NLTX

3.49 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)